Main > INFECTIOUS DISEASES > USA. G. HCV Infection>Treat. S+V>

---

USA. G. HCV Infection>Treat. S+V>'s subsections
(*) EU CE Mark Date Adults: 2016
(*) USA Adults OK: 2016
(*) USA Pediatrics OK: 2020. 03.19
>NS5B Inh.+Velpatasvir Tablets
Company
Generic Name: Sofosbuvir
NS: Non-Structural
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 3
Patent>UpDate: 2021. 12.28
RTM
RTM Web-Site

USA. G. HCV Infection>Treat. S+V>'s products
This section has no products